Adicet Bio Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

152

Market Cap

80.64M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	24.99M	15.26M	156.83%
Dec 31, 2021	9.73M	-8.17M	-45.65%
Dec 31, 2020	17.90M	16.91M	1,699.30%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

ACET News

14 days ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
5 weeks ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
6 weeks ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
6 weeks ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
2 months ago - Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) - Business Wire
2 months ago - Adicet Bio, Inc. - Special Call - Seeking Alpha
2 months ago - Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 - Benzinga
2 months ago - Adicet Bio, Inc. Announces $80 Million Registered Direct Offering - Business Wire

More News